Volume 1, Issue 2, Summer 2024

View Volume 1, Issue 2, Summer 2024

Current and Emerging Treatment Options for HER2-Positive Gastroesophageal Cancer
Current Uses and Pitfalls of Liquid Biopsy in NSCLC
From Intractable to Treatable: Milestones and Horizons in the Management of HER2+ Breast Cancer
Survivorship Issues in Testicular Cancer
An Evolving Paradigm in Borderline Resectable and Locally Advanced Pancreatic Cancer: Current Strategies and Opportunities for the Future

Published: 2024-06-20

Full Issue

Articles

Current and Emerging Treatment Options for HER2‑Positive Gastroesophageal Cancer

Ronan A. McLaughlin, MD, Elena Elimova, MD

4–11
- PDF (en)
- PDF (fr)
Current Uses and Pitfalls of Liquid Biopsy in NSCLC

Nadia Ghazali, BMed, Natasha B. Leighl, MD, MMSc, FRCPC, FASCO

12–18
- PDF (en)
- PDF (fr)
From Intractable to Treatable: Milestones and Horizons in the Management of HER2+ Breast Cancer

Meredith Li, MD, David W. Cescon, MD, PhD, FRCPC

20–26
- PDF (en)
- PDF (fr)
Survivorship Issues in Testicular Cancer

Marco Pisino, MD, Lucia Nappi, MD

28–36
- PDF (en)
- PDF (fr)
An Evolving Paradigm in Borderline Resectable and Locally Advanced Pancreatic Cancer: Current Strategies and Opportunities for the Future

Arman Zereshkian, MD, Erica S. Tsang, MD

37–50
- PDF (en)
- PDF (fr)